Showing results (831-840 of 3,636) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|March 25, 2025
Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year periodG Giannone, P Lombardi, M Filetti, et al.
Breast (Edinburgh, Scotland)|March 27, 2025
Long-term outcomes of three distinct once-daily schedules for accelerated partial breast irradiationLorenzo Vinante, Michele Avanzo, Angela Caroli, et al.
Breast (Edinburgh, Scotland)|March 27, 2025
Switching to T-DM1 remains justified in patients with HER2-negative residual invasive breast cancer after neoadjuvant therapyCharles E Geyer, Sibylle Loibl
Breast (Edinburgh, Scotland)|May 30, 2024
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional studyFrancesco Schettini, Silvana Saracchini, Anna Bassini, et al.
Breast (Edinburgh, Scotland)|May 17, 2024
Impact of neoadjuvant compared to adjuvant chemotherapy on prognosis in patients with hormone-receptor positive / HER2-negative breast cancer: A propensity score matching population-based studyServah Hosseini-Mellner, Åsa Wickberg, Andreas Karakatsanis, et al.
Breast (Edinburgh, Scotland)|June 16, 2024
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancerSerena Di Cosimo, José Manuel Pérez-García, Meritxell Bellet, et al.
Breast (Edinburgh, Scotland)|December 14, 2025
Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patientsJ Meijer, H J G D van den Bongard, L B Koppert, et al.
Breast (Edinburgh, Scotland)|November 26, 2025
Ensuring access to multidisciplinary care in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 4)Shani Paluch-Shimon, Laura Biganzoli, Julie Torode, et al.
Breast (Edinburgh, Scotland)|November 26, 2025
Collecting high-quality data for advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 2)Vicki Durston, Charlotte E Coles, Adele Gautier, et al.
Breast (Edinburgh, Scotland)|May 11, 2024
Screening optimal candidates with operable, early-stage triple-negative breast cancer benefitting from capecitabine maintenance: A post-hoc analysis of the SYSUCC-001 studyFangfang Duan, Xin Hua, Xiwen Bi, et al.
Pageof 364